3-Hydroxypropionic Acid Fermentation Without External B12
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing 3-hydroxypropionic acid (3-HP) are inefficient and require external supplementation of coenzyme B12, limiting production yields.
Innovation Solution
Development of genetically modified Pseudomonas strains with engineered expression systems, including tandem promoters and optimized gene sequences, to produce 3-HP without external coenzyme B12 supplementation, enhancing metabolic pathways and minimizing toxic intermediates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If genetically modified Pseudomonas strains with engineered expression systems are used, then 3-HP production titer increases to high levels without external B12 supplementation, but the strain development and process optimization complexity increases
Solution Approach 1:
The expression system is segmented into multiple functional components: tandem promoters (first and second promoters) for independent control, optimized gene sequences for enhanced expression, and modular genetic constructs. This segmentation allows independent optimization of each component to achieve high 3-HP titers without external B12 supplementation.
Solution Approach 2:
The expression system employs dynamic control through inducible promoters that respond to environmental signals and metabolic states. The tandem promoter configuration allows differential regulation of gene expression levels based on growth phase and substrate availability, enabling high productivity without external cofactor supplementation.
2Productivity
If external coenzyme B12 supplementation is required, then production yield is limited, but the process simplicity is maintained
Solution Approach 1:
The genetically modified Pseudomonas strains possess endogenous capability to synthesize coenzyme B12 through engineered metabolic pathways. The bacteria self-supplement the required cofactor internally, eliminating the need for external B12 supplementation and thereby increasing production yield without significantly complicating the manufacturing process.
Solution Approach 2:
The strains are pre-engineered with complete B12 synthesis pathways before production. This preliminary genetic modification ensures that the bacteria possess inherent B12 production capability from the outset, eliminating the need for external supplementation during the production phase and maintaining process simplicity.
3Productivity
If metabolic pathways are enhanced to minimize toxic intermediates, then 3-HP production efficiency improves, but the genetic engineering complexity increases
Solution Approach 1:
The metabolic pathway is segmented into distinct enzymatic steps, each controlled by specific promoter elements and regulatory sequences. This segmentation allows targeted optimization of rate-limiting steps and efficient removal of toxic intermediates through controlled expression of pathway enzymes, improving production efficiency while managing engineering complexity through modular design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified strains achieve high titers of 3-HP production, reaching up to 100 g/L without external B12, improving efficiency and yield.
Implementation Method 1
methods of producing 3-HP or a salt thereof from glycerol using a genetically modified strain of Pseudomonas denitrificans
Data Source
AI summary
The disclosure provides methods and apparatus for producing 3-hydroxypropionic acid or a salt thereof, for removing 3-hydroxypropionic acid from aqueous solution (e.g., aqueous broth), and for using it to make various chemicals.